{
  "docId": "019de072-f883-7038-87b7-1190d38538fc",
  "docSlug": "b2613cd3e65595fa61ed3ce545efa4c9",
  "documentTitle": "Exscientia | Investor Presentation Deck | 37 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 37,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide highlights a major partnership deal as evidence of market traction and validation of the platform.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-f883-7038-87b7-1190d38538fc/7",
  "deckHref": "/decks/019de072-f883-7038-87b7-1190d38538fc",
  "deckJsonHref": "/decks/019de072-f883-7038-87b7-1190d38538fc.json",
  "deckAnchorHref": "/decks/019de072-f883-7038-87b7-1190d38538fc#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.38,
        "x": 0.58,
        "y": 0.22
      },
      "kind": "callout",
      "text": "Financial terms: $100 million upfront payment, potential $5.2 billion total payments; Up to $343 million per target in potential payments including $193 million for research, development and regulatory milestones and up to $150 million for commercial milestones; High-single digit to mid-teens tiered royalties; Exscientia co-investment option increases royalty rate to 21% on net sales of co-funded products",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa28d688-8210-4dca-aef8-2b5078ac42fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.12,
        "x": 0.71,
        "y": 0.24
      },
      "kind": "image",
      "text": "sanofi",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71df7c95-e98e-4cc5-a247-97961b2a941a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.45,
        "x": 0.08,
        "y": 0.28
      },
      "kind": "list",
      "text": "Leveraging Exscientia’s end-to-end AI capabilities allows for fundamentally improved overall process; Exscientia leading target discovery, drug design and translational activities up to candidate nomination; Sanofi bringing deep therapeutic area and biology expertise, as well as clinical and commercial capabilities; Up to 15 small molecule targets across oncology and immunology; Economics reflect Exscientia’s value creation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d64054a8-cd15-4150-a875-c41a864863b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.08,
        "y": 0.14
      },
      "kind": "title",
      "text": "Utilises Exscientia’s platform from idea generation through patient selection",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d38b114-e4bd-4cdc-8d7c-29629764ce56",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.08,
        "y": 0.07
      },
      "kind": "title",
      "text": "Deal highlights industry shift in drug discovery",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b36d872e-3627-416d-8425-7c36526a2f22",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 13,
      "from": 4,
      "beatId": "d82d668f-ad4f-4c5b-8d76-893faac92e36",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "The deck presents traction metrics on slides 4-13",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 37,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "7b15f9dd-8590-4693-8bcf-77e7f6a4d27a",
      "evidence": "The deck presents a clear narrative around Exscientia's strategy and its benefits throughout",
      "position": 1,
      "objective": "Explain Exscientia's patient-first AI strategy and its benefits",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}